Affinergy

Home

Technology

Leadership

About Us


Leadership







Peyton Anderson

Peyton Anderson, MBA
Chief Executive Officer


Peyton is a successful entrepreneur who co-founded SciQuest, Inc. in 1995 as its founding CEO. SciQuest raised over $175 million in capital, including a successful Initial Public Offering in 1999. His responsibilities included raising capital, recruiting the management team, doing strategic partner deals, and orchestrating 8 acquisitions. SciQuest has continued to thrive and currently has greater than 150 employees.

Peyton joined Affinergy in September 2003 as founding CEO. Since that time, Affinergy has secured $5m in investor funding, been awarded numerous peer-review grants, added 23 employees, recruited a strong team of advisors / Board members, and committed to developing multiple products in the orthopedic and soft tissue repair markets.

Peyton will continue to expand Affinergy's leadership team by recruiting professionals in quality, manufacturing, clinical, sales, and marketing.

Peyton currently serves on the Board of Directors of the North Carolina Biotechnology Center and the NC Biosciences Organization. Previously, he served on the executive committee of the Board of Directors for the Council for Entrepreneurial Development.

Peyton is a frequent speaker at entrepreneurial conferences and MBA classes. Peyton graduated Phi Beta Kappa from the U. of Richmond in 1989 and earned his MBA from UNC's Kenan Flagler Business School in 1995.

spacer Jonathan Gindes

Jonathan Gindes, MBA, RAC
Chief Financial Officer and Senior Vice-President of Business Development


Jonathan and Affinergy's scientific co-founders (M. Grinstaff, D. Kenan) began working together in 2002 to form Affinergy while Jonathan pursued his M.B.A. at Duke's Fuqua School of Business. Jonathan developed Affinergy's initial business strategy, negotiated the technology license from Duke University, and recruited a senior management team along with other scientific staff and business advisors.

Presently, in addition to managing Affinergy’s daily financial affairs, Jonathan focuses his time procuring sufficient capital to enable the rapid growth of Affinergy, whether through grants and other growth capital sources. Jonathan plays an active role on the operations side of Affinergy, as well, and supervises the sourcing of all of Affinergy’s equipment and supplies. He also is responsible for securing relationships and supply agreements with component suppliers for Affinergy’s future products.

Prior to attending Fuqua, Jonathan spent several years working alongside senior management in the corporate strategy group at Deutsche Bank. His work focused on merger integration, growth and consolidation strategies, and business plan development for potential spinouts.

Jonathan received his Bachelor of Arts degree in Economics from Rutgers University. He serves on the board of the Council for Entrepreneurial Development as well as Fuqua’s Entrepreneurship and Venture Capital Club and is a frequent lecturer to Global Executive and Full-Time MBA programs at the Fuqua School of Business. He also became certified in regulatory affairs (RAC) in 2009 and was recently a recipient of the Triangle Business Journal’s CFO of the year award.






Daniel Kenan

Daniel Kenan, M.D., Ph.D.
Scientific Co-Founder


Dan is an Assistant Professor of Pathology at Duke University Medical Center. Dan received his Ph.D. in Microbiology and Immunology at Duke. He later received his M.D. at Duke where he continued residency training in Pathology.

In 1997, Dan became the Director of the Combinatorial Sciences Center at Duke. Dan has published more than 30 manuscripts and is the principal investigator on 4 NIH grants.

spacer Mark Greenstaff

Mark Grinstaff, Ph.D.
Scientific Co-Founder


Mark is an Associate Professor of Chemistry and Biomedical Engineering at Boston University. This professorship is funded by a $14MM Whitaker Foundation Leadership Award. Mark received his Ph.D. from U. of Illinois and was an NIH Postdoctoral Fellow at the California Institute of Technology.

Mark has published over 60 manuscripts. His awards include the ACS Nobel Laureate Signature Award, NSF Career Award, Pew Scholar in the Biomedical Sciences, Camille Dreyfus Teacher-Scholar, and an Alfred P. Sloan Research Fellowship.





Key Advisors



Jack Blair, M.B.A., was President of Smith & Nephew Richards Inc. and member of the Board of Smith & Nephew from 1989 to 1998, time at which he retired from the company. Jack presently serves as non-executive Chairman of dj Orthopedics, Inc., and as a director of NuVasive, Inc and Buckman Laboratories.

spacer

Chris Fair, has over 15 years of orthopedic device management and development experience. Prior to joining MedShape Solutions, Inc., Chris served as the VP of Sales & Marketing for St. Francis Medical Technologies. Chris played an key role in the development of the company, the launch of the XSTOP and ultimately the sale of the company to Kyphon Inc. for $725MM. Prior to St. Francis, Chris held management positions with DePuy Spine for 10 years.

spacer

Jonathan Grauer, MD, serves as Co-Director of Orthopaedic Spine Services and Associate Professor in the Department of Orthopaedics and Rehabilitation at Yale University School of Medicine. He completed his Orthopaedic Surgery residency at Yale New Haven Hospital and a fellowship in spine surgery at the Rothman Institute at Thomas Jefferson University. He has authored or co-authored over 75 peer-reviewed scientific papers, 50 reviews, and 50 book chapters and participates on the review boards of several peer-reviewed journals in orthopaedics.



Farshid Guilak, Ph.D., is an Associate Professor of Surgery and Director of Research for the Division of Orthopaedic Surgery at Duke University Medical Center. He serves as co-Director of Duke's Center for Biomolecular and Tissue Engineering.

spacer

William Marston, MD, is Chief of the Division of Vascular Surgery and Professor in the Department of Surgery at UNC-Chapel Hill. Dr. Marston is also the Medical Director of the UNC Wound Healing & Podiatry Center. He holds a medical degree from the University of Virginia and did his residency and fellowship at UNC-Chapel Hill.

spacer

Preston B. Rich, MD, MBA, FACS, is the chief surgeon of trauma, critical care and emergency general surgery in the Division of Trauma and Critical Care Surgery at the UNC School of Medicine. He is also Associate Professor in the Department of Surgery at UNC-Chapel Hill. Dr. Rich received his medical degree from the Medical College of Virginia, VCU, and did his residency and fellowship at the University of Michigan.